Jan 13 (Reuters) - Proxy advisory firm Ownership Matters said on Monday it recommends that shareholders of Sigma Healthcare SIG.AX vote in favour of Chemist Warehouse's reverse takeover of the pharmaceutical company, citing significant shareholder value.
Sigma Healthcare will conduct a shareholder meeting on Jan. 29 to seek approval for the deal, which will create a $5.8 billion entity.
As part of the deal, which was announced in December 2023, Chemist Warehouse will buy Sigma for stock and A$700 million in cash, giving it a roughly 85% stake in the merged entity and a back door to list on the Australian stock exchange.
In early November, the Australian competition regulator cleared the deal after the companies made concessions to alleviate competition concerns.
Shares of Sigma Healthcare have surged more than 300% since the announcement of the deal. It was last down 1.2% at A$2.965.
(Reporting by John Biju in Bengaluru; Editing by Sonia Cheema)
((John.Biju@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。